Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli

Background: Microglial activation after systemic infection has been suggested to mediate sepsis-associated delirium. A systematic review of animal studies suggested distinct differences between microglial activation after systemic challenge with live bacteria and lipopolysaccharide (LPS). Here, we d...

Full description

Bibliographic Details
Main Authors: Inge C. M. Hoogland, Dunja Westhoff, Joo-Yeon Engelen-Lee, Jeroen Melief, Mercedes Valls Serón, Judith H. M. P. Houben-Weerts, Inge Huitinga, David J. van Westerloo, Tom van der Poll, Willem A. van Gool, Diederik van de Beek
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fncel.2018.00110/full
_version_ 1811226087202488320
author Inge C. M. Hoogland
Dunja Westhoff
Joo-Yeon Engelen-Lee
Jeroen Melief
Mercedes Valls Serón
Judith H. M. P. Houben-Weerts
Inge Huitinga
David J. van Westerloo
Tom van der Poll
Willem A. van Gool
Diederik van de Beek
author_facet Inge C. M. Hoogland
Dunja Westhoff
Joo-Yeon Engelen-Lee
Jeroen Melief
Mercedes Valls Serón
Judith H. M. P. Houben-Weerts
Inge Huitinga
David J. van Westerloo
Tom van der Poll
Willem A. van Gool
Diederik van de Beek
author_sort Inge C. M. Hoogland
collection DOAJ
description Background: Microglial activation after systemic infection has been suggested to mediate sepsis-associated delirium. A systematic review of animal studies suggested distinct differences between microglial activation after systemic challenge with live bacteria and lipopolysaccharide (LPS). Here, we describe a mouse model of microglial activation after systemic challenge with live Escherichia coli (E. coli) and compare results with systemic challenge with LPS.Methods: Sixty mice were intraperitoneally injected with E. coli (1 × 104 colony-forming units) and sacrificed at 12, 20, 48, and 72 h after inoculation. For 48 and 72 h time points, mice were treated with ceftriaxone. Thirty mice were intraperitoneally injected with LPS (5 mg/kg) and sacrificed 3 and 48 h after inoculation; 48 control mice were intraperitoneally injected with isotonic saline. Microglial response was monitored by immunohistochemical staining with Iba-1 antibody and flow cytometry; and inflammatory response by mRNA expression of pro- and anti-inflammatory mediators.Results: Mice infected with live E. coli showed microglial activation 72 h post-inoculation, with increased cell number in cortex (p = 0.0002), hippocampus (p = 0.003), and thalamus (p = 0.0001), but not in the caudate nucleus/putamen (p = 0.33), as compared to controls. At 72 h, flow cytometry of microglia from E. coli infected mice showed increased cell size (p = 0.03) and CD45 expression (p = 0.03), but no increase in CD11b expression, and no differences in brain mRNA expression of inflammatory mediators as compared to controls. In mice with systemic LPS stimulation, microglial cells were morphologically activated at the 48 h time point with increased cell numbers in cortex (p = 0.002), hippocampus (p = 0.0003), thalamus (p = 0.007), and caudate nucleus/putamen (p < 0.0001), as compared to controls. At 48 h, flow cytometry of microglia from LPS stimulated mice showed increased cell size (p = 0.03), CD45 (p = 0.03), and CD11b (p = 0.04) expression. Brain mRNA expression of TNF-α (p = 0.02), IL-1β (p = 0.02), and MCP-1 (p = 0.03) were increased as compared to controls.Interpretation: Systemic challenge with live E. coli causes a neuro-inflammatory response, but this response occurs at a later time point and is less vigorous as compared to LPS stimulation.The E. coli model mimics the clinical situation of infection associated delirium more closely than stimulation with supra-natural LPS.
first_indexed 2024-04-12T09:18:28Z
format Article
id doaj.art-91a8d9dfa4fe468c8723a19ba8fe8c93
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-12T09:18:28Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-91a8d9dfa4fe468c8723a19ba8fe8c932022-12-22T03:38:45ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022018-04-011210.3389/fncel.2018.00110352494Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coliInge C. M. Hoogland0Dunja Westhoff1Joo-Yeon Engelen-Lee2Jeroen Melief3Mercedes Valls Serón4Judith H. M. P. Houben-Weerts5Inge Huitinga6David J. van Westerloo7Tom van der Poll8Willem A. van Gool9Diederik van de Beek10Department of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsNetherlands Institute for Neuroscience - KNAW, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsNetherlands Institute for Neuroscience - KNAW, Amsterdam, NetherlandsIntensive Care Medicine, Leiden University Medical Center, Leiden, NetherlandsCenter of Experimental Molecular Medicine, Academic Medical Center, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsBackground: Microglial activation after systemic infection has been suggested to mediate sepsis-associated delirium. A systematic review of animal studies suggested distinct differences between microglial activation after systemic challenge with live bacteria and lipopolysaccharide (LPS). Here, we describe a mouse model of microglial activation after systemic challenge with live Escherichia coli (E. coli) and compare results with systemic challenge with LPS.Methods: Sixty mice were intraperitoneally injected with E. coli (1 × 104 colony-forming units) and sacrificed at 12, 20, 48, and 72 h after inoculation. For 48 and 72 h time points, mice were treated with ceftriaxone. Thirty mice were intraperitoneally injected with LPS (5 mg/kg) and sacrificed 3 and 48 h after inoculation; 48 control mice were intraperitoneally injected with isotonic saline. Microglial response was monitored by immunohistochemical staining with Iba-1 antibody and flow cytometry; and inflammatory response by mRNA expression of pro- and anti-inflammatory mediators.Results: Mice infected with live E. coli showed microglial activation 72 h post-inoculation, with increased cell number in cortex (p = 0.0002), hippocampus (p = 0.003), and thalamus (p = 0.0001), but not in the caudate nucleus/putamen (p = 0.33), as compared to controls. At 72 h, flow cytometry of microglia from E. coli infected mice showed increased cell size (p = 0.03) and CD45 expression (p = 0.03), but no increase in CD11b expression, and no differences in brain mRNA expression of inflammatory mediators as compared to controls. In mice with systemic LPS stimulation, microglial cells were morphologically activated at the 48 h time point with increased cell numbers in cortex (p = 0.002), hippocampus (p = 0.0003), thalamus (p = 0.007), and caudate nucleus/putamen (p < 0.0001), as compared to controls. At 48 h, flow cytometry of microglia from LPS stimulated mice showed increased cell size (p = 0.03), CD45 (p = 0.03), and CD11b (p = 0.04) expression. Brain mRNA expression of TNF-α (p = 0.02), IL-1β (p = 0.02), and MCP-1 (p = 0.03) were increased as compared to controls.Interpretation: Systemic challenge with live E. coli causes a neuro-inflammatory response, but this response occurs at a later time point and is less vigorous as compared to LPS stimulation.The E. coli model mimics the clinical situation of infection associated delirium more closely than stimulation with supra-natural LPS.http://journal.frontiersin.org/article/10.3389/fncel.2018.00110/fullmicrogliamicroglial activationsystemic infectionlipopolysaccharideEscherichia colineuro-inflammation
spellingShingle Inge C. M. Hoogland
Dunja Westhoff
Joo-Yeon Engelen-Lee
Jeroen Melief
Mercedes Valls Serón
Judith H. M. P. Houben-Weerts
Inge Huitinga
David J. van Westerloo
Tom van der Poll
Willem A. van Gool
Diederik van de Beek
Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
Frontiers in Cellular Neuroscience
microglia
microglial activation
systemic infection
lipopolysaccharide
Escherichia coli
neuro-inflammation
title Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
title_full Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
title_fullStr Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
title_full_unstemmed Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
title_short Microglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
title_sort microglial activation after systemic stimulation with lipopolysaccharide and escherichia coli
topic microglia
microglial activation
systemic infection
lipopolysaccharide
Escherichia coli
neuro-inflammation
url http://journal.frontiersin.org/article/10.3389/fncel.2018.00110/full
work_keys_str_mv AT ingecmhoogland microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT dunjawesthoff microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT jooyeonengelenlee microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT jeroenmelief microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT mercedesvallsseron microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT judithhmphoubenweerts microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT ingehuitinga microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT davidjvanwesterloo microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT tomvanderpoll microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT willemavangool microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli
AT diederikvandebeek microglialactivationaftersystemicstimulationwithlipopolysaccharideandescherichiacoli